Skip to main content

Table 5 Distribution of clinical manifestations according to HLA-B*5 1 and HLA-A status

From: Associations between the HLA-Apolymorphism and the clinical manifestations of Behcet's disease

Patient subset

n(%) of clinical manifestations

OR (95% CI)

P

 

Skin lesions

  

B*51+ A*02:07+

8/8 (100)

NA

0.20

B*51- A*02:07+

17/19 (89.5)

2.86 (0.63 to 13.10)

0.24

B*51+ A*02:07-

63/73 (86.3)

2.12 (0.97 to 4.64)

0.055

B*51- A*02:07-

92/123 (74.8)

(referent)

 
 

Uveitis

  

B*51+ A*26:01+

4/7 (57.1)

3.10 (0.66 to 14.53)

0.21

B*51- A*26:01+

11/19 (57.9)

3.20 (1.19 to 8.59)

0.017

B*51+ A*26:01-

33/74 ((44.6)

1.87 (1.03 to 3.40)

0.039

B*51- A*26:01-

37/123 (30.1)

(referent)

 
  1. CI, confidence intervals; NA, not applicable; OR, odds ratio.